ARVINAS, INC. Toevoegen aan een lijst
Financiële vergelijkingen Arvinas, Inc.
Aandelen
ARVN
US04335A1051
Biotechnologie & Medisch Onderzoek
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 25,12 USD | +2,95% |
|
-3,98% | -38,97% |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Omzet ($) (Y-1) | Nettomarge (Y-1) | Bedrijfsmarge (Y-1) | ROE (Y-1) | ROA (Y-1) | Hefboom (schuld/EBITDA) (Y-1) | |
|---|---|---|---|---|---|---|---|
| 78,5 mln. | -467.90% | -511.46% | -59.97% | - | 3.18x | ||
| 13,12 mld. | +30.14% | +39.08% | +20.74% | +16.20% | -1.6x | ||
| 9,87 mld. | +36.68% | +44.33% | +22.99% | +17.71% | -2.46x | ||
| 1,29 mld. | -23.26% | -33.51% | -8.54% | -7.69% | 10.14x | ||
| 4,22 mld. | +24.36% | +18.08% | +4.62% | +4.02% | -13.1x | ||
| 2,46 mld. | -35.86% | -49.12% | -22.26% | -14.47% | 2.05x | ||
| 2,44 mld. | +26.42% | +32.30% | +14.78% | +13.31% | -5.01x | ||
| 5,67 mld. | +26.50% | +29.43% | +18.99% | +15.45% | -0.64x | ||
| 1,24 mld. | -43.11% | -21.54% | -86.15% | -1.86% | 1.96x | ||
| 305 mln. | -245.59% | -232.51% | - | -50.20% | -0.8x | ||
| 1,89 mld. | +13.23% | +13.30% | +12.68% | +8.89% | -5.76x | ||
| 285 mln. | -181.75% | -144.69% | -51.94% | -32.60% | 2.5x | ||
| 50,7 mln. | -205.30% | -166.94% | -58.43% | - | 2.98x | ||
| 829 mln. | +33.96% | +40.71% | +293.15% | +20.80% | 2.73x | ||
| 1,83 mld. | +11.35% | +9.34% | +8.74% | +6.91% | -5.06x | ||
| 159 mln. | -12.22% | -37.48% | -3.46% | -2.93% | 11.91x | ||
| 294 mln. | -180.51% | -170.79% | -818.43% | -50.27% | -0.33x | ||
| Gemiddelde | 2,71 mld. | -70,17% | -67,15% | -44,53% | -3,78% | 0,16x | |
| Gewogen gemiddelde per kap. | 7,29 mld. | -1,23% | +4,18% | +0,09% | +7,42% | -1,06x |
- Beurs
- Aandelen
- Koers ARVN
- Sector Arvinas, Inc.
- Financiële vergelijkingen
